Melinda Dawn Bernal, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 38 Anaya Rd, Belen, NM 87002 Phone: 505-864-7812 Fax: 505-864-7812 |
Carolyn Siebert Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 N Main St, Belen, NM 87002 Phone: 505-966-1506 |
Cynthia Y Medina Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1831 Camino Del Llano, Belen, NM 87002 Phone: 505-864-1600 |
Lisa Burnson Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1831 Camino Del Llano, Belen, NM 87002 Phone: 505-864-1600 |
Tara Monroe, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1609 Jack Nicklaus Dr, Belen, NM 87002 Phone: 505-859-0098 |
Brenda Yoshino Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 N Main St, Belen, NM 87002 Phone: 505-966-1506 |
Robert Maranan Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 N Main St, Belen, NM 87002 Phone: 505-966-1506 |
Sarah Toso Geuder Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 520 N Main St, Belen, NM 87002 Phone: 505-966-1506 |
News Archive
Mount Sinai researchers have created a novel model that shows the step-by-step progression from normal blood cells to leukemia and its precursor diseases, creating replicas of the stages of the disease to test the efficacy of therapeutic interventions at each stage, according to a study to be published in Cell Stem Cell.
Researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center are reporting a potentially important discovery in the battle against one of the most devastating forms of leukemia that accounts for as many as one in five children with a particularly aggressive form of the disease relapsing within a decade.
Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has filed its annual report for the fiscal year ended December 31, 2009 on Form 20-F with the U.S. Securities and Exchange Commission on June 30, 2010.
University of Louisville bioengineering researchers will use a $3.33 million award from the Wallace H. Coulter Foundation to help commercialize promising academic innovations into medical solutions to benefit patients.
Scientists at Queen's University Belfast have shown that they can deliver a gene directly into breast cancer cells causing them to self-destruct, using an innovative, miniscule gene transport system, according to research published today in the International Journal of Pharmaceutics.
› Verified 6 days ago